Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk to discuss a collaboration with FairJourney Biologics. Allan explains what this collaboration will cover, what will it mean for Cizzle Biotech, more about FairJourney and where the main focus will be over the next 6 months.
Cizzle Biotechnology is a UK based developer of A blood test for the early detection of a majority of different forms of lung cancer.
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.
